Circa Group AS announced a strategic technology partnership with EKATO. The agreement that has been signed with EKATO will see Circa incorporate EKATO's hydrogenation technology in the development of its ReSolute plant, which will be commissioned in June 2024. The partnership also covers future commercial scale plants including FC6, which is in the planning stages.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 NOK | +1.82% | +15.94% | -67.54% |
05-15 | Transcript : Circa Group AS, Q1 2024 Earnings Call, May 15, 2024 | |
05-03 | CIRCA Group AS and IXOM Operations Pty Ltd Partner to Develop the Market for Cyrene in Australia and New Zealand | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.54% | 12.52M | |
-5.78% | 4.3B | |
+14.70% | 1.83B | |
-12.61% | 641M | |
-13.17% | 463M | |
-81.65% | 216M | |
-12.94% | 113M | |
-12.68% | 53.73M |
- Stock Market
- Equities
- CIRCA Stock
- News Circa Group
- Circa Group AS and EKATO Sign Strategic Technology Agreement